fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Mutual Funds » TATA India PHARMA Healthcare Fund

TATA India PHARMA & Healthcare Fund - G

NAV  ₹15.7701 ↑ 0.09  (0.56 %) as on 19 Apr 21

Scheme Objective

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund launched on 28 Dec 15. It is a fund with High risk and has given a CAGR return of 9% since its launch.  Return for 2020 was 64.4% , 2019 was 5.5% and 2018 was -2.6% .

Below is the key information for TATA India Pharma & Healthcare Fund

NAV as on 19 Apr 21₹15.7701 ↑ 0.09  (0.56 %)
Net Assets (AUM) as on 28 Feb 2021 ₹413 Cr.
Launch Date28 Dec 2015
CategoryEquity - Sectoral
RatingNot Rated
TypeOpen Ended Fund
RiskHigh
AMCTata Asset Management Limited
Alpha Ratio3.33
Expense Ratio2.61 %
Sharpe Ratio1.478
Information Ratio0.67
BenchmarkNot Available
Min Investment ₹5,000
Min SIP Investment ₹500
Exit Load 0-3 Months (0.25%),3 Months and above(NIL)

Returns

Annual Compounded Returns

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Apr 21

DurationReturns
1 Month 11.9%
3 Month 3.8%
6 Month 16.3%
1 Year 48.1%
3 Year 21.8%
5 Year 10.4%
10 Year
15 Year
Since launch 9%

Historical Annual Returns

Historical performance (Yearly) on absolute basis

YearReturns
2020 64.4%
2019 5.5%
2018 -2.6%
2017 4.7%
2016 -14.7%
2015
2014
2013
2012

Growth of 10k Over Years

DateValue
31 Mar 16₹10,000
31 Mar 17₹9,719
31 Mar 18₹8,904
31 Mar 19₹9,694
31 Mar 20₹9,527
31 Mar 21₹15,709
TATA India PHARMA & Healthcare Fund Growth 10k Chart

Asset Allocation

Asset ClassValue
Cash2.42%
Equity97.58%
TATA India PHARMA & Healthcare Fund Asset Allocation

Sector Allocation

SectorValue
Health Care97.58%
TATA India PHARMA & Healthcare Fund Equity Allocation

Top Securities Holdings / Portfolio

Holdings/Securities

NameGlobal IndustryHoldingValueQuantity
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 18 | 500124
Drug Manufacturers - Specialty & Generic15%₹60 Cr135,500
↑ 27,900
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA
Drug Manufacturers - Specialty & Generic10%₹41 Cr690,100
Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 500087
Drug Manufacturers - General9%₹36 Cr460,000
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
Drug Manufacturers - Specialty & Generic8%₹31 Cr92,500
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA
Drug Manufacturers - Specialty & Generic7%₹29 Cr335,000
↑ 190,000
Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | ALKEM
Drug Manufacturers - Specialty & Generic6%₹26 Cr95,365
↑ 6,165
Ipca Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 16 | 524494
Drug Manufacturers - Specialty & Generic6%₹23 Cr125,426
Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP
Medical Care Facilities5%₹22 Cr70,500
Procter & Gamble Health Ltd Shs Dematerialised (Healthcare)
Equity, Since 31 Jul 18 | 500126
Drug Manufacturers - Specialty & Generic4%₹17 Cr26,000
Narayana Hrudayalaya Ltd (Healthcare)
Equity, Since 29 Feb 20 | NH
Medical Care Facilities4%₹16 Cr376,420
↓ -280,300
1 - 10 of 26
Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Fund Managers

NameSinceTenure
Rahul Singh20 Apr 200.95 Yr.
Meeta Shetty20 Apr 200.95 Yr.

Custodians

CompanyAddress
Deutsche Bank AGDeutsche Bank AG,Kodak House, 22, D.N. Road,

Registrar & Transfer Agent

Computer Age Management Services Ltd
AddressNew No.10, Old No.178,,Kodambakkam High Road,,Opp. Hotel Palmgrove,,Nungambakkam
FAX91-44-28283610
Emailenq_L@camsonline.com

Administrator Companies

CompanyAddress
Tata Mutual Fund1903, B-Wing, Parinee Crescenzo,,G-Block, Bandra Kurla Complex, Bandra East Mumbai 400051

Auditors

CompanyAddress
Deloitte Haskins & Sells12, Dr. Annie Besant Road, Opp. Shiv Sagar Estate,,Worli
M/s BSR & Co.KPMG House, Kamala Mills Compound,448 Senapati Bapat Marg,Lower Parel

All Plan & Options

Fund and PlanNAV6 Month1 Year3 Year5 Year
TATA India Pharma & Healthcare Fund
Normal Dividend, Reinvestment
₹15.7701
↑ 0.09
16.3 %48.13 %21.78 %10.36 %
TATA India Pharma & Healthcare Fund
Normal Dividend, Payout
₹15.7701
↑ 0.09
16.3 %48.13 %21.78 %10.36 %
TATA India Pharma & Healthcare Fund
Growth
₹15.7701
↑ 0.09
16.3 %48.13 %21.78 %10.36 %
Data as on 19 Apr 21

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.